Lensoside Aβ as an Adjuvant to the Anti-Glioma Potential of Sorafenib.

Aleksandra MaciejczykJustyna Kapral-PiotrowskaJoanna Sumorek-WiadroAdrian ZającEwa GrelaRafal Luchowski Wieslaw I GruszeckiMarta Kinga LemieszekIwona Wertel Łukasz Pecio Jerzy Żuchowski Krystyna Skalicka WoźniakBożena Pawlikowska-PawlęgaMonika Hułas-StasiakWojciech Rzeski Radosław Rola Joanna Jakubowicz-Gil

Published in: Cancers (2021)

Our results indicate that lensoside Aβ plays an important role as an adjuvant in chemotherapy with sorafenib and may be a potential candidate in anti-glioma combination therapy.

Keyphrases

combination therapy
early stage
human health
locally advanced
squamous cell carcinoma